2-Chloro-N6,N6-dimethyl-2’-deoxyadenosine manufacturers
|
| | 2-Chloro-N6,N6-dimethyl-2’-deoxyadenosine Basic information |
| Product Name: | 2-Chloro-N6,N6-dimethyl-2’-deoxyadenosine | | Synonyms: | 2-Chloro-N6,N6-dimethyl-2’-deoxyadenosine;Adenosine, 2-chloro-2'-deoxy-N,N-dimethyl-;(2R,3R,4R,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(5-ethynyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite | | CAS: | 1858191-70-4 | | MF: | C12H16ClN5O3 | | MW: | 313.74 | | EINECS: | | | Product Categories: | | | Mol File: | 1858191-70-4.mol |  |
| | 2-Chloro-N6,N6-dimethyl-2’-deoxyadenosine Chemical Properties |
| Boiling point | 511.1±60.0 °C(Predicted) | | density | 1.69±0.1 g/cm3(Predicted) | | pka | 13.75±0.60(Predicted) |
| | 2-Chloro-N6,N6-dimethyl-2’-deoxyadenosine Usage And Synthesis |
| Uses | 2-Chloro-2′-deoxy-N,N-dimethyladenosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 2-Chloro-N6,N6-dimethyl-2’-deoxyadenosine Preparation Products And Raw materials |
|